Iovance
IOVA

Iovance (IOVA) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
TD CowenMaintainedBuy$10.00 from $7.00Aug 25, 2026
UBSMaintainedNeutral$7.00 from $4.00Aug 20, 2026
MizuhoMaintainedOutperform$11.00 from $10.00Aug 18, 2026
CitizensMaintainedMarket Outperform$8.00 from $5.00Aug 7, 2026
BarclaysMaintainedOverweight$13.00 from $11.00Aug 7, 2026
Chardan CapitalMaintainedBuy$14.00 from $16.00May 7, 2026
Chardan CapitalMaintainedBuy$16.00Apr 10, 2026
UBSMaintainedNeutral$4.00 from $2.00Mar 5, 2026
CitizensUpgradedMarket Perform → Market Outperform$5.00Mar 3, 2026
BarclaysMaintainedOverweight$11.00 from $10.00Feb 25, 2026
CitizensUpgradedMarket Perform → Market Outperform$5.00Feb 25, 2026
BarclaysMaintainedOverweight$10.00 from $9.00Dec 17, 2025
BarclaysMaintainedOverweight$9.00 from $4.00Nov 24, 2025
Chardan CapitalMaintainedBuy$17.00 from $20.00Nov 6, 2025
HC Wainwright & Co.MaintainedBuy$9.00 from $20.00Oct 29, 2025
HC Wainwright & Co.MaintainedBuy$20.00Aug 19, 2025
Chardan CapitalMaintainedBuy$20.00 from $25.00Aug 8, 2025
Wells FargoMaintainedOverweight$14.00 from $18.00Aug 8, 2025
Chardan CapitalMaintainedBuy$25.00Jul 23, 2025
UBSDowngradedBuy → Neutral$2.00 from $17.00May 16, 2025

Frequently asked questions

  • What is the latest analyst rating on IOVA?

    On Aug 25, 2026, TD Cowen maintained Iovance at Buy with a price target of $10.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.